⁠⁠SPEECH BIOMARKERS OF PREMORBIDITY

 

Cluster of multimorbid diseases associated with thrombosis

 

Epidemiology

Thrombosis is a family of diseases that includes thrombosis of arteries and veins. Thrombosis is the leading global cause of death, given its role in the pathogenesis of coronary heart disease, myocardial infarction, ischemic stroke and venous thromboembolism. There has been a notable deceleration in the rate of decline in cardiovascular disease mortality across the majority of countries, affecting both men and women, particularly those within the 35 to 74 age range. The global incidence rates per 100,000 individuals for various cardiovascular diseases and conditions, including coronary heart disease (1518.7), myocardial infarction (139.3), ischemic stroke (114.3), atrial fibrillation (59.5–77.5), and venous thromboembolism (115–269), are presented in the following table. Mortality rates for ischemic heart disease (105.5), ischemic stroke (42.3), atrial fibrillation (1.7), and pulmonary embolism (9.4–32.3) are presented.

 

Problem

There is currently no consensus regarding the diagnostic criteria for multimorbidity. The majority of solutions are based on the diagnosis of diseases and the monitoring of both hereditary and acquired factors. In addition to pregnancy and postpartum, major surgery, immobilization, cancer and chronic inflammatory diseases, acquired risk factors traditionally include behavioral risk factors, which are well studied and poorly corrected, often because of the little attention paid by the doctor and the patient to their presence. It is important to remember that these are so-called modifiable risk factors, which means they can be corrected. Consistent with neuroimmune mechanisms, it is important to emphasize that behavioral deviations in diet and lifestyle are a consequence rather than a cause, and are formed during ontogenesis, embryogenesis, and long before birth. 

Current approaches to diagnostics and interventions are disease-specific and can only prolong life in poor health and disability, and aim to increase the burden on both the patient and the health care system. It is important to recognize that conventional methods of intervention, which rely on the prescription of pharmaceuticals and surgical procedures, are inadequate for addressing this issue. The management of arterial and venous thrombosis is approached in different ways. The various scenarios of pharmacotherapy for arterial thrombosis are summarized by the administration of antiplatelet agents, and the treatment of venous thrombosis with a wide range of anticoagulant agents.  
It was determined that behavioral risk factors exhibited the greatest number of correlations with multimorbidity. It can thus be concluded that multimorbidity is not an obligatory condition that is characteristic of the aging population; rather, it is a consequence of the patient's behavior. Nevertheless, this narrow perspective undoubtedly distorts the actuality of the situation through the substitution of cause and effect. 
The classic view is that the physician and nurse should identify risk factors for thrombosis-associated multimorbidity as early as possible. This should be achieved by entering relevant information in the patient's electronic medical record and regularly monitoring the progression of these factors. And intervention should consist of preventive counselling by the physician to support self-management. It is evident that this approach is destined to be ineffective due to the inherent discrepancy between the predicted model of the external environment and the actual incoming signals. Preventative counseling cannot alter the fundamental nature of this predicted model of the patient's world.

 

Solution

This solution aims to identify premorbid condition using speech biomarkers. This aims to detect such conditions to reduce the likelihood of altering the homeostasis trajectory towards the development of a cluster of multimorbidity associated with thrombosis.

Speech biomarkers of premorbidity and a smartphone application module to monitor them

MULTYMORBID
SOLUTION
Innovative solutions based on artificial intelligence and neuroimmunology
Сайт создан на A5